Commitment COM-112
Post-approval commitment for HSA-2023-0012. Category: Pharmacovigilance. Priority: medium.
Commitment ID
COM-112
Application
Authority
Health Sciences Authority
Category
Pharmacovigilance
Priority
medium
Status
Overdue
Due Date
2025-04-14
Completed At
—
Owner
Nadia Petrova
Created
2022-11-02
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.